News

GPs call for increased allergy test access

13-Oct-08

Half of GPs believe the key to improving allergy services is to increase access to testing facilities in primary care, a survey has found.

Of the 204 GPs questioned as part of the research, 47 per cent believed that increased availability of allergy testing would reduce the need to refer patients to specialists. In addition, 64 per cent believed it would lead to more accurate diagnoses.

The survey also showed that 80 per cent of GPs believe that diagnosis and treatment of allergies should take place in primary care.

The research was conducted by Phadia, a company which develops allergy testing equipment. A spokesman for the company said that better testing for GPs would ensure patients could manage their own conditions, possibly by avoiding particular allergens, rather than taking medicine.

tom.moberly@haymarket.com

Comment below and tell us what you think

Comments

Only registered users may comment. Log in now or register for a free account.

There are problems with your form submission.

Please review the errors shown below.



Forgot your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Nursing Professional Issues

Supporting victims of childhood sexual abuse

Health professionals can help patients recover from psychosexual trauma, writes Graham Wilmer. Read More

Rise of the GP-led health centres

As the new 'super-surgeries' open, we consider the possible opportunities for nurses. Joe Lepper rep... Read More

Career Profile - Staff nurse, eating disorders service

Daniel Brown, Roehampton, London Read More

Show all articles

Latest Clinical Articles

Abnormal uterine bleeding

Contributed by Mr Antonio V Antoniou, consultant gynaecologist and lead in minimal access surgery an... Read more

Chronic low back pain

Dr Mark Ritchie, GPSI in pain management, Morriston, Swansea Read more

Acute and sub-acute back pain

Contributed by Dr Mark Ritchie, GPSI in pain management, Morriston, Swansea Read more

Show all clinical articles

MIMS Product News

New drug - Stelara

Janssen-Cilag has launched Stelara for the treatment of moderate to severe plaque psoriasis where ot... Read more

New high-strength nicotine patch

Nicorette Invisipatch is the latest addition to the range of available nicotine replacement therapy ... Read more

Prolonged-release aspirin

Flamasacard, a prolonged-release formulation of aspirin, for secondary prophylaxis after a first cor... Read more

Jobs